Low levels of mutant ubiquitin are degraded by the proteasome in vivo

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Neuroscience Research

• Publication date

  2010-08-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/jnr.22396PMID 20336771
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanisms of cross‐talk between the ubiquitin‐proteasome and autophagy‐lysosome systems

  2010cited by this paper
• Aging Is Not Associated with Proteasome Impairment in UPS Reporter Mice

  2009cited by this paper
• Long-term proteasome dysfunction in the mouse brain by expression of aberrant ubiquitin.

  2009cited by this paper
• Recognition and processing of ubiquitin-protein conjugates by the proteasome.

  2009cited by this paper
• The neuronal ubiquitin-proteasome system: murine models and their neurological phenotype.

  2008cited by this paper
• Dose-dependent inhibition of proteasome activity by a mutant ubiquitin associated with neurodegenerative disease

  2007cited by this paper
• Mutant ubiquitin found in Alzheimer's disease causes neuritic beading of mitochondria in association with neuronal degeneration

  2007cited by this paper
• Proteasome-Independent Functions of Ubiquitin in Endocytosis and Signaling

  2007cited by this paper
• Frameshift proteins in autosomal dominant forms of Alzheimer disease and other tauopathies

  2006cited by this paper
• CHIP-mediated stress recovery by sequential ubiquitination of substrates and Hsp70

  2006cited by this paper
• Ubiquitin and ubiquitin-like proteins as multifunctional signals

  2005cited by this paper
• The proteasome in Alzheimer's disease and Parkinson's disease: lessons from ubiquitin B+1.

  2005cited by this paper
• The Subunit Structure and Dynamics of the 20S Proteasome in Chicken Skeletal Muscle*

  2005cited by this paper
• Proteasome inhibition by lactacystin in primary neuronal cells induces both potentially neuroprotective and pro‐apoptotic transcriptional responses: a microarray analysis

  2005cited by this paper
• Proteasomal activity in brain differs between species and brain regions and changes with age.

  2005cited by this paper
• Mutant ubiquitin UBB+1 is accumulated in sporadic inclusion-body myositis muscle fibers

  2004cited by this paper
• Accumulation of aberrant ubiquitin induces aggregate formation and cell death in polyglutamine diseases.

  2004cited by this paper
• The development of proteasome inhibitors as anticancer drugs.

  2004cited by this paper
• Inhibitors of the eukaryotic 20S proteasome core particle: a structural approach.

  2004cited by this paper
• The mouse brain in stereotaxic coordinates

  2003cited by this paper
• The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg.

  2003cited by this paper
• Proteasome inhibitors induce growth inhibition and apoptosis in myeloma cell lines and in human bone marrow myeloma cells irrespective of chromosome 13 deletion

  2003cited by this paper
• Alzheimer's associated variant ubiquitin causes inhibition of the 26S proteasome and chaperone expression

  2003cited by this paper
• Disease‐specific accumulation of mutant ubiquitin as a marker for proteasomal dysfunction in the brain

  2003cited by this paper
• Fine Structure and Biochemical Mechanisms Underlying Nigrostriatal Inclusions and Cell Death after Proteasome Inhibition

  2003cited by this paper
• Frameshifted β-Amyloid Precursor Protein (APP+1) Is a Secretory Protein, and the Level of APP+1 in Cerebrospinal Fluid Is Linked to Alzheimer Pathology*

  2003cited by this paper
• Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation

  2002cited by this paper
• Recommendations for the health monitoring of rodent and rabbit colonies in breeding and experimental units

  2002cited by this paper
• Control genes and variability: absence of ubiquitous reference transcripts in diverse mammalian expression studies.

  2002cited by this paper
• Molecular misreading of the ubiquitin B gene and hepatic mallory body formation.

  2002cited by this paper
• Impairment of the ubiquitin‐proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures

  2002cited by this paper
• Impairment of proteasome structure and function in aging.

  2002cited by this paper
• The proteasome in brain aging.

  2002cited by this paper
• The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction.

  2002cited by this paper
• Mutant ubiquitin expressed in Alzheimer's disease causes neuronal death1

  2001cited by this paper
• Proteasome inhibitors: from research tools to drug candidates.

  2001cited by this paper
• Comparison of human adult and fetal expression and identification of 535 housekeeping/maintenance genes.

  2000cited by this paper
• Inhibition of the ubiquitin-proteasome system in Alzheimer's disease.

  2000cited by this paper
• Decreased levels of proteasome activity and proteasome expression in aging spinal cord.

  2000cited by this paper
• Proteasome Inhibitors Induce Cytochrome c–Caspase-3-Like Protease-Mediated Apoptosis in Cultured Cortical Neurons

  2000cited by this paper
• Lactacystin, a specific inhibitor of the proteasome, induces apoptosis and activates caspase‐3 in cultured cerebellar granule cells

  2000cited by this paper
• Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids.

  1998influential reference
• 72-kDa Heat Shock Protein and mRNA Expression after Controlled Cortical Impact Injury with Hypoxemia in Rats

  1998cited by this paper
• Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients.

  1998cited by this paper
• Mechanistic Studies on the Inactivation of the Proteasome by Lactacystin

  1996cited by this paper
• Control of Memory Formation Through Regulated Expression of a CaMKII Transgene

  1996influential reference
• Purification and characterization of Lewy bodies from the brains of patients with diffuse Lewy body disease.

  1996influential reference
• Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin

  1995influential reference
• Effects of implantation of Alzet 1007D osmotic minipumps upon 2-deoxyglucose uptake in the cerebral cortex of mice.

  1993cited by this paper
• A generic intron increases gene expression in transgenic mice

  1991cited by this paper
• Induction of a heat shock gene at the site of tissue injury in the rat brain.

  1989cited by this paper
• THE UNLABELED ANTIBODY ENZYME METHOD OF IMMUNOHISTOCHEMISTRY PREPARATION AND PROPERTIES OF SOLUBLE ANTIGEN-ANTIBODY COMPLEX (HORSERADISH PEROXIDASE-ANTIHORSERADISH PEROXIDASE) AND ITS USE IN IDENTIFICATION OF SPIROCHETES

  1970cited by this paper

• The Dose-Dependent Pleiotropic Effects of the UBB+1 Ubiquitin Mutant

  2021cites this paper
• Effects of a Nanoencapsulated Moringa Leaf Ethanolic Extract on the Physiology, Metabolism and Reproductive Performance of Rabbit Does during Summer

  2021cites this paper
• Paradoxical effects of mutant ubiquitin on Aβ plaque formation in an Alzheimer mouse model.

  2018cites this paper
• Dysfunction of Protein Quality Control in Parkinsonism–Dementia Complex of Guam

  2018cites this paper
• On protein quality control, myofibrillar myopathies, and neurodegeneration

  2017cites this paper
• On protein quality control, myofibrillar myopathies, and neurodegeneration

  2017cites this paper
• On protein quality control, myofibrillar myopathies, and neurodegeneration

  2017cites this paper
• Selective Transgenic Expression of Mutant Ubiquitin in Purkinje Cell Stripes in the Cerebellum

  2016cites this paper
• Polyglutamine aggregation in Huntington's disease and spinocerebellar ataxia type 3: similar mechanisms in aggregate formation

  2016cites this paper
• Accumulation of Basic Am ino Acids at Mitochondria Dictates the Cytotoxicity of Aberrant Ubiquitin Graphical

  2015cites this paper
• Accumulation of Basic Amino Acids at Mitochondria Dictates the Cytotoxicity of Aberrant Ubiquitin

  2015cites this paper
• Ubiquitin-dependent proteolysis in yeast cells expressing neurotoxic proteins

  2015cites this paper
• Mutant Ubiquitin UBB+1 Induces Mitochondrial Fusion by Destabilizing Mitochondrial Fission-Specific Proteins and Confers Resistance to Oxidative Stress-Induced Cell Death in Astrocytic Cells

  2014cites this paper
• Cellular protein quality control and the evolution of aggregates in spinocerebellar ataxia type 3 (SCA3)

  2012cites this paper
• Pathophysiology of protein aggregation and extended phenotyping in filaminopathy.

  2012cites this paper
• Review: Unchained maladie – a reassessment of the role of Ubb+1‐capped polyubiquitin chains in Alzheimer's disease

  2012cites this paper
• The ubiquitin proteasome system in neurodegenerative diseases: culprit, accomplice or victim?

  2012cites this paper
• Impairment of ubiquitin-proteasome system by E334K cMyBPC modifies channel proteins, leading to electrophysiological dysfunction.

  2011cites this paper
• On protein quality control, myofibrillar myopathies, and neurodegeneration

  year unknowncites this paper